Chapter 11 Flashcards

1
Q

Which of the following statements is incorrect regarding memory B cells?

a. Memory B cells are maintained for life.
b. In secondary responses, the number of pathogen-specific B cells is about 10–100-fold that seen in primary responses.
c. The sensitivity of memory B cells is improved compared with naive B bells because affinity maturation has occurred.
d. Memory B cells express lower levels of MHC class II and B7 than do naive B cells.
e. Memory B cells differentiate into plasma cells more rapidly than do naive B cells.

A

Memory B cells express lower levels of MHC class II and B7 than do naive B cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which of the following characterizes immunological memory? (Select all that apply.)

a. The host retains the capacity to mount a secondary immune response.
b. The host retains the ability to respond to pathogen many years after primary exposure.
c. Naive T cells are activated more quickly when exposed to pathogen.
d. Memory B cells produce higher-affinity antibody than naive B cells.
e. Memory T cells undergo somatic hypermutation.
f. Memory T cells express CD45RA.

A

a. The host retains the capacity to mount a secondary immune response.
b. The host retains the ability to respond to pathogen many years after primary exposure.
d. Memory B cells produce higher-affinity antibody than naive B cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What would be the outcome if a naive B cell were to bind to pathogen coated with specific antibody made by an effector B cell in a primary immune response using FcγRIIB1, and simultaneously bind to the same pathogen using its B-cell receptor?

a. a positive signal leading to the production of low-affinity IgM antibodies
b. a positive signal leading to isotype switching and the production of IgG, IgA, or IgE antibodies
c. a positive signal leading to somatic hypermutation and the production of high-affinity IgM antibodies
d. a negative signal leading to inhibition of the production of low-affinity IgM antibodies
e. a negative signal leading to apoptosis

A

a negative signal leading to inhibition of the production of low-affinity IgM antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which of the following explains why the first baby born to a RhD– mother and a RhD+ father does not develop hemolytic disease of the newborn?

a. Fetal erythrocytes do not cross the placenta and therefore do not stimulate an antibody response.
b. The antibodies made by the RhD– mother during the first pregnancy are predominantly IgM and have low affinity for the Rhesus antigen.
c. Maternal macrophages in the placenta bind to anti-Rhesus antibodies and prevent their transfer to the fetus.
d. Hemolytic disease of the newborn is a T-cell-mediated disease and maternal T cells do not cross the placenta during pregnancy.
e. The Rhesus antigen is not immunogenic and does not stimulate an antibody response.

A

The antibodies made by the RhD– mother during the first pregnancy are predominantly IgM and have low affinity for the Rhesus antigen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

By which process are fetal erythrocytes destroyed in hemolytic anemia of the newborn?

a. lysis of erythrocytes by cytotoxic T cells
b. lysis of erythrocytes by complement activation
c. clearance of antibody-coated erythrocytes by macrophages in the fetal spleen
d. lysis of erythrocytes by NK cells via antibody-dependent cell-mediated cytotoxicity
e. cytotoxicity caused by major basic protein released from eosinophils

A

clearance of antibody-coated erythrocytes by macrophages in the fetal spleen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When a naive B cell binds to an IgG:antigen complex on its cell surface using FcγRIIB1, while simultaneously binding to the same antigen using membrane-bound IgM, _____.

a. the IgG:antigen complex is endocytosed
b. the B cell becomes anergic
c. the B cell will switch isotype to IgG
d. the B cell undergoes affinity maturation
e. the B cell secretes large amounts of IgM before becoming a memory B cell

A

the B cell becomes anergic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

“Original antigenic sin” is best described as a phenomenon in which _____.

a. a highly mutable virus gradually escapes from immunological memory and interferes with compensatory immune responses.
b. latent viruses periodically activate effector T cells specific for the original antigen recognized in the primary immune response.
c. the persistence of antigen is necessary to sustain maintenance of immunological memory.
d. memory T cells no longer express the same profile of adhesion molecules and cytokine receptors compared with the original profile of the naive precursor T cell.

A

a highly mutable virus gradually escapes from immunological memory and interferes with compensatory immune responses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Imagine a situation in which an individual who has a latent cytomegalovirus (CMV) infection receives a hematopoietic stem-cell transplant. Which of the following is likely to occur?

a. The memory T cells present at the time of transplantation would inhibit activation of newly generated naive T cells.
b. The CMV viral load would increase exponentially, overcoming the host and causing death.
c. The transplant-derived naive T cells would be activated and give rise to memory T cells that would persist and control viral load.
d. There would be a rapid increase in CMV viral load and expansion of T cells bearing CD45RA.

A

The transplant-derived naive T cells would be activated and give rise to memory T cells that would persist and control viral load.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which of the following are not a component of immunological memory?

a. effector B cells
b. memory T cells
c. memory B cells
d. long-lived plasma cells

A

effector B cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The efficiency and specificity of adaptive immune defenses and immunological memory improve each time a particular pathogen is encountered because _____.

a. of protective immunity
b. effector memory T cells outnumber central memory T cells
c. the half-life of antibodies made in secondary and tertiary immune responses exceeds that of antibodies made in primary immune responses.
d. of affinity maturation

A

of affinity maturation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Unlike naive lymphocytes, memory lymphocytes _____.

a. do not recirculate between the blood and secondary lymphoid organs
b. do not require the receipt of survival signals through their antigen receptors in order to persist
c. are immortal and continue to divide throughout the lifetime of an individual
d. secrete antibody continuously, although at a much lower rate than plasma cells
e. do not express CD27

A

do not require the receipt of survival signals through their antigen receptors in order to persist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

All of the following are ways in which plasma cells differ from memory cells except _____.

a. plasma cells lack surface immunoglobulin
b. cellular morphology
c. plasma cells are CD27-negative
d. plasma cells have undergone isotype switching
e. plasma cells are short-lived

A

plasma cells have undergone isotype switching

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

During a secondary immune response, high-affinity IgG antibodies are produced. Which of the following best explains why low-affinity IgM antibodies are not made?

a. Naive pathogen-specific B cells are suppressed by negative signaling through FcγRIIB1.
b. Naive pathogen-specific B cells isotype switch and hypermutate much more quickly during secondary immune responses.
c. Memory B cells outnumber naive B cells.
d. Low-affinity IgM antibodies are made only when antigen concentration is exceedingly high.

A

Naive pathogen-specific B cells are suppressed by negative signaling through FcγRIIB1.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which of the following molecules is not elevated on the surface of memory B cells compared with naive B cells?

a. MHC class II molecules
b. CD45RA
c. antigen receptor
d. CD27
e. co-stimulatory molecules

A

CD45RA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

_____ accounts for the production of different isoforms of the CD45 protein observed in naive, effector, and memory T cells.

a. Isotype switching
b. Affinity maturation
c. Alternative splicing
d. Somatic hypermutation
e. Recirculation to peripheral tissues

A

Alternative splicing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Memory B cells differ from memory T cells in the following ways. (Select all that apply.)

a. They suppress naive antigen-specific lymphocytes during secondary immune responses.
b. They recirculate only through secondary lymphoid organs.
c. They secrete their antigen receptors throughout their life-span.
d. They generate long-lived clones of memory cells during the primary immune response.

A

a. They suppress naive antigen-specific lymphocytes during secondary immune responses.
b. They recirculate only through secondary lymphoid organs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

RhoGAM is administered to pregnant RhD– women so as to _____. (Select all that apply.)

a. stimulate only anti-RhD IgM antibody
b. cause selective removal of anti-RhD memory B cells from the maternal circulation
c. inhibit a primary immune response to RhD antigen
d. block transcytosis of IgG to fetal circulation by interfering with FcRn function
e. prevent hemolytic anemia of the newborn

A

c. inhibit a primary immune response to RhD antigen

e. prevent hemolytic anemia of the newborn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Identify the mismatched pair. (Select all that apply.)

a. variolation: smallpox
b. Salk vaccine: killed poliovirus
c. vaccinia virus: cowpox
d. rotavirus: segmented DNA virus
e. Sabin vaccine: TVOP
f. rabies vaccine: live attenuated vaccine

A

d. rotavirus: segmented DNA virus

f. rabies vaccine: live attenuated vaccine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Recombinant DNA technology has been especially useful for the production of _____ that are used in subunit vaccines.

a. viral proteins
b. viral nucleic acids
c. mutated viruses
d. viral polysaccharides
e. infectious particles

A

viral proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

With reference to RotaTaq, identify the incorrect statement. (Select all that apply.)

a. It is an attenuated vaccine derived from a human rotavirus.
b. It has been genetically engineered to express a variety of human VP4 and VP7 glycoproteins.
c. It is a mixture of five cattle rotaviruses.
d. It is nonpathogenic in humans unless a genetic reversion occurs.
e. Standard tissue culture methods are used for its production.
f. It took decades of research to develop this vaccine to an adequate standard.

A

a. It is an attenuated vaccine derived from a human rotavirus.
d. It is nonpathogenic in humans unless a genetic reversion occurs.

21
Q

Which of the following is an example of a subunit vaccine? (Select all that apply.)

a. hepatitis B vaccine
b. Bacille Calmette–Guérin (BCG) vaccine
c. trivalent oral polio vaccine
d. influenza vaccine
e. Bexsero®

A

a. hepatitis B vaccine

e. Bexsero®

22
Q

All of the following are examples of adjuvants except _____.

a. alum
b. MF59
c. inactivated Bordetella pertussis
d. virosomes
e. RhoGAM

A

RhoGAM

23
Q

A newly identified antigen protein of Neisseria meningitidis called fHbp increases virulence by _____.

a. interfering with the alternative pathway of complement activation
b. binding to host-derived heparin
c. increasing the adhesiveness of the bacterium
d. inhibiting phagocytosis
e. inducing inflammation

A

interfering with the alternative pathway of complement activation

24
Q

_____ is the approach that mines a pathogen’s genome to reveal potential antigens and derives clues about cellular location, function, and ability to stimulate protective antibodies based on nucleotide sequence.

a. Conjugation
b. Attenuation
c. Reverse vaccinology
d. Herd immunity
e. Neutralization

A

Reverse vaccinology

25
Q

The reason that vaccines against influenza must be administered annually, unlike vaccines against measles, is _____.

a. the antigens that stimulate protection against influenza virus are inside the virion and not on the surface
b. influenza is an RNA virus with a higher mutation rate
c. influenza stimulates T-independent responses that fail to generate memory cells
d. the polysaccharide antigens of influenza stimulate poor immune responses

A

influenza is an RNA virus with a higher mutation rate

26
Q

When a subpopulation of unvaccinated individuals are protected against a pathogen because the vast majority of individuals in the overall population are vaccinated, this is called _____.

a. reverse vaccinology
b. subunit vaccination
c. partial immunization
d. combined immunity
e. herd immunity

A

herd immunity

27
Q

After a campus outbreak of Neisseria meningitidis (meningococcal serogroup B), a devastating bacterial disease, which affected at least eight students at Princeton University, the US Food and Drug Administration approved the use of Bexsero to prevent the development of additional cases on that campus. Bexsero is considered to provide broader protective coverage than the US-licenced vaccines conventionally used against this disease. Which of the following methodologies was used to develop Bexsero?

a. conjugation of neisserial capsular polysaccharide to tetanus toxoid
b. reverse vaccinology
c. formalin treatment of secreted toxins
d. production of a combination vaccine that includes DTP plus a meningococcal polysaccharide diphtheria toxoid conjugate
e. engineering a nonpathogenic cattle strain of N. meningitidis to express antigens associated with pathogenic human strains

A

reverse vaccinology

28
Q

Bacterial vaccines differ from viral vaccines in that only in bacterial vaccines are _____ used. (Select all that apply.)

a. subunit components
b. toxoids
c. whole infectious components
d. capsular polysaccharides
e. capsule:carrier protein conjugates

A

b. toxoids
d. capsular polysaccharides
e. capsule:carrier protein conjugates

29
Q

40 Reasons complicating the development of vaccines to combat chronic diseases include _____. (Select all that apply.)

a. evasion of the host’s immune system by the pathogen
b. the polymorphic diversity of MHC class I and class II molecules
c. the generation of inappropriate immune responses that do not eradicate the pathogen
d. survival of the infectious agent for long periods inside the host
e. high mutation rates in the pathogen

A

a. evasion of the host’s immune system by the pathogen
b. the polymorphic diversity of MHC class I and class II molecules
c. the generation of inappropriate immune responses that do not eradicate the pathogen
d. survival of the infectious agent for long periods inside the host
e. high mutation rates in the pathogen

30
Q

On an otherwise uneventful sunny Sunday afternoon, an extremist group enters your city in a large van and drives to the front entrance of the Convention Center where the annual flower show is taking place. The occupants unload large crates resembling flats of assorted flowers, and then drive off. Within minutes the crates explode, showering the visitors with an opaque powder. Medical teams are called to the scene to care for the injured, and CDC officials wearing level 4 containment suits arrive in a few hours to test the contents of the powder for human pathogens using multiplex PCR methodology (a rapid method for identifying pathogens by their DNA). Which of the following potential bioterrorism agents would pose the most serious threat to those exposed?

a. Bacillus anthracis (anthrax)
b. Corynebacterium diphtheriae toxin (diphtheria)
c. Yersinia pestis (plague)
d. variola major (smallpox)
e. Clostridium botulinum toxin (botulism)

A

variola major (smallpox)

31
Q

In which ways do memory B cells active in a secondary immune response differ from the naive B-cell population activated in a primary immune response? (Select all that apply.)

a. The antibody produced is of higher affinity in a secondary immune response.
b. The frequency of antigen-specific B cells is lower in a secondary immune response.
c. The level of somatic hypermutation is higher in a secondary immune response.
d. Higher levels of IgM are produced in secondary immune responses.
e. B cells do not require T-cell help in secondary immune responses.
f. Memory B cells express higher levels of MHC class II molecules.
g. Naive B cells express higher levels of co-stimulatory molecules.

A

a. The antibody produced is of higher affinity in a secondary immune response.
c. The level of somatic hypermutation is higher in a secondary immune response.
f. Memory B cells express higher levels of MHC class II molecules.

32
Q

Which of the following explain why infections with influenza virus erode immunological memory over time? (Select all that apply.)

a. Influenza is a highly mutable virus that changes its epitope composition.
b. A compensatory immune response to new epitope variants is suppressed in naive B cells.
c. The antibody response is directed only toward new epitope variants, resulting in a decreased memory response.
d. Cross-linking of B-cell receptor and FcγRIIB1 on memory B cells induces anergy.
e. Naive B cells are suppressed by cytokines made by memory B cells.

A

a. Influenza is a highly mutable virus that changes its epitope composition.
b. A compensatory immune response to new epitope variants is suppressed in naive B cells.

33
Q

Naive T cells do not express _____. (Select all that apply.)

a. CD25
b. CD45RA
c. CCR7
d. IFN-γ
e. FasL

A

a. CD25
d. IFN-γ
e. FasL

34
Q

The production of CD45RO results from the removal of _____ during _____ processing.

a. domain A; post-translational
b. domain A; post-transcriptional
c. exons A, B, and C; post-translational
d. exons A, B, and C; post-transcriptional
e. exon A; post-transcriptional

A

exons A, B, and C; post-transcriptional

35
Q

Effector memory cells enter _____, whereas central memory cells enter _____.

a. B-cell follicles; T-cell zones of secondary lymphoid tissues
b. T-cell zones of secondary lymphoid tissues; B-cell follicles
c. secondary lymphoid tissues; primary lymphoid tissues
d. T-cell zones of secondary lymphoid tissues; inflamed tissues
e. inflamed tissues; T-cell zones of secondary lymphoid tissues

A

inflamed tissues; T-cell zones of secondary lymphoid tissues

36
Q

_____ involves deliberate stimulation of the immune system and induction of protective immunity to a particular disease-causing pathogen by mimicking infection in the absence of disease.

a. Variolation
b. Attenuation
c. Vaccination
d. Conjugation
e. Herd immunity

A

Vaccination

37
Q

Inactivation of viruses for vaccine use can be achieved by _____. (Select all that apply.)

a. irradiation
b. heat treatment
c. mutation
d. neutralization
e. formalin treatment

A

a. irradiation
b. heat treatment
e. formalin treatment

38
Q

An example of a live-attenuated virus vaccine is _____. (Select all that apply.)

a. vaccinia
b. Salk polio vaccine
c. measles vaccine
d. yellow fever vaccine
e. rabies vaccine

A

c. measles vaccine

d. yellow fever vaccine

39
Q

An example of an inactivated virus vaccine is _____. (Select all that apply.)

a. Sabin polio vaccine
b. influenza vaccine
c. mumps vaccine
d. hepatitis B vaccine
e. rabies vaccine

A

b. influenza vaccine

e. rabies vaccine

40
Q

For a viral subunit vaccine to be effective, _____. (Select all that apply.)

a. B cells must be activated
b. cytotoxic T cells must be activated
c. neutralizing antibodies must be induced
d. CD4 TFH cells must be activated
e. NK cells must be activated
f. it must be derived from viral surface components

A

a. B cells must be activated
c. neutralizing antibodies must be induced
d. CD4 TFH cells must be activated
f. it must be derived from viral surface components

41
Q

A conjugate vaccine is one that couples _____ to _____ so as to stimulate T-dependent antibody responses.

a. polysaccharide; a protein carrier
b. a protein carrier; irradiated DNA
c. protein carrier; toxoids
d. adjuvant; toxoids
e. polysaccharide; filamentous hemagglutinin

A

polysaccharide; a protein carrier

42
Q

_____ vaccines are the most effective at evoking memory responses against a virus in an immunized host.

a. Conjugate
b. Subunit
c. Killed
d. Live-attenuated
e. Toxoid

A

Live-attenuated

43
Q

Which of the following vaccines is least likely to pose a risk in an individual with an immunodeficiency?

a. Sabin polio vaccine
b. measles vaccine
c. hepatitis B vaccine
d. vaccinia vaccine
e. yellow fever vaccine

A

hepatitis B vaccine

44
Q

Approximately one-quarter of individuals infected with hepatitis C _____.

a. develop a chronic infection of hepatocytes
b. are at risk of developing liver cancer
c. experience episodes of liver destruction and regeneration
d. require a liver transplant
e. mount an effective immune response and eradicate the virus

A

mount an effective immune response and eradicate the virus

45
Q

Which of the following explain why the safety standards for vaccines are set higher than those for drugs? (Select all that apply.)

a. Some vaccines can induce a disease state.
b. Vaccines provoke side-effects in otherwise healthy children.
c. Vaccines are much more costly to develop and test than most drugs.
d. Vaccination programs are targeted at large populations.
e. Subunit vaccines can potentially integrate into the host genome and activate host oncogenes, leading to the development of cancer.

A

a. Some vaccines can induce a disease state.
b. Vaccines provoke side-effects in otherwise healthy children.
d. Vaccination programs are targeted at large populations.

46
Q

An adjuvant enhances the effectiveness of vaccines by inducing the expression of _____ on ________.

a. co-stimulatory molecules; dendritic cells
b. CD28; macrophages
c. MHC class II molecules; T cells
d. T-cell receptor; T cells
e. immunoreceptor tyrosine-based activation motifs; dendritic cells

A

co-stimulatory molecules; dendritic cells

47
Q

Tim Smith, aged 16 years, was hit by a car while riding his motorcycle. At the hospital he showed only minor abrasions and no bone fractures. He was discharged later that day. In the morning he experienced severe abdominal pain and returned to the hospital. Examination revealed tachycardia, low blood pressure, and a weak pulse. He received a blood transfusion without improvement. Laparoscopic surgery confirmed peritoneal hemorrhage due to a ruptured spleen. In addition to a splenectomy, which of the following treatments would be administered?

a. plasmapheresis to remove autoantibodies (antibodies generated against self constituents)
b. regular intravenous injections of gamma globulin
c. vaccination and regular boosters with capsular polysaccharides from pathogenic pneumococcal strains
d. booster immunization with DTP (diphtheria toxoid, killed Bordetella pertussis, and tetanus toxoid)
e. regular blood transfusions

A

vaccination and regular boosters with capsular polysaccharides from pathogenic pneumococcal strains

48
Q

Jenny O’Mara was five months pregnant when she stepped on a rusty piece of scrap metal while hauling rotted wood from a dilapidated shed in her garden. The sliver of metal cut through her sneaker and pierced her heel deeply. Her physician gave her a tetanus booster. When Jenny’s baby was born she decided to breastfeed. If the baby’s antibodies were tested for specificity to tetanus 2 months after birth, what would be the expected finding?

a. the presence of anti-tetanus toxoid IgA antibodies
b. the presence of anti-tetanus toxoid IgM antibodies
c. the presence of anti-tetanus toxoid IgG antibodies
d. the presence of IgM antibody specific for Clostridium tetani cell-wall components
e. the presence of IgG antibody specific for Clostridium tetani cell-wall components

A

the presence of anti-tetanus toxoid IgG antibodies